HMGB1 and arteriosclerosis disorder: The current study aimed to evaluate whether the differentiation of MSCs to vascular cells would be influenced by high mobility group box 1 (HMGB1) and whether it could be used to provide favorable outcomes of MSC-based therapy for transplant arteriosclerosis.